Article ; Online: IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
2020 Volume 11, Issue 1
Abstract: Interferon-induced transmembrane (IFITM) proteins are encoded by many vertebrate species and exhibit antiviral activities against a wide range of viruses. IFITM3, when present in virus-producing cells, reduces the fusion potential of HIV-1 virions, but ... ...
| Abstract | Interferon-induced transmembrane (IFITM) proteins are encoded by many vertebrate species and exhibit antiviral activities against a wide range of viruses. IFITM3, when present in virus-producing cells, reduces the fusion potential of HIV-1 virions, but the mechanism is poorly understood. To define the breadth and mechanistic basis for the antiviral activity of IFITM3, we took advantage of a murine leukemia virus (MLV)-based pseudotyping system. By carefully controlling amounts of IFITM3 and envelope protein (Env) in virus-producing cells, we found that IFITM3 potently inhibits MLV infectivity when Env levels are limiting. Loss of infectivity was associated with defective proteolytic processing of Env and lysosomal degradation of the Env precursor. Ecotropic and xenotropic variants of MLV Env, as well as HIV-1 Env and vesicular stomatitis virus glycoprotein (VSV-G), are sensitive to IFITM3, whereas Ebola glycoprotein is resistant, suggesting that IFITM3 selectively inactivates certain viral glycoproteins. Furthermore, endogenous IFITM3 in human and murine cells negatively regulates MLV Env abundance. However, we found that the negative impact of IFITM3 on virion infectivity is greater than its impact on decreasing Env incorporation, suggesting that IFITM3 may impair Env function, as well as reduce the amount of Env in virions. Finally, we demonstrate that loss of virion infectivity mediated by IFITM3 is reversed by the expression of glycoGag, a murine retrovirus accessory protein previously shown to antagonize the antiviral activity of SERINC proteins. Overall, we show that IFITM3 impairs virion infectivity by regulating Env quantity and function but that enhanced Env expression and glycoGag confer viral resistance to IFITM3. |
|---|---|
| MeSH term(s) | Animals ; HIV-1/physiology ; Host-Pathogen Interactions/immunology ; Humans ; Immunity, Innate ; Leukemia Virus, Murine/physiology ; Lysosomes/metabolism ; Membrane Proteins/metabolism ; Mice ; Protein Binding ; Protein Transport ; Proteolysis ; RNA-Binding Proteins/metabolism ; Retroviridae/physiology ; Retroviridae Infections/immunology ; Retroviridae Infections/metabolism ; Retroviridae Infections/virology ; Viral Envelope Proteins/immunology ; Viral Envelope Proteins/metabolism |
| Chemical Substances | IFITM3 protein, human ; Membrane Proteins ; RNA-Binding Proteins ; Viral Envelope Proteins |
| Language | English |
| Publishing date | 2020-01-21 |
| Publishing country | United States |
| Document type | Journal Article |
| ZDB-ID | 2557172-2 |
| ISSN | 2150-7511 ; 2161-2129 |
| ISSN (online) | 2150-7511 |
| ISSN | 2161-2129 |
| DOI | 10.1128/mBio.03088-19 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.